IRF1 and colitis: IRF1 was found to significantly reduce colorectal cancer incidence in mice, and its induction of PANoptosis was effective in preventing AOM/DSS‐induced colorectal cancer, while Irf1‐deficient mice exhibited an abnormal susceptibility to colitis‐associated colorectal tumors.